The store will not work correctly when cookies are disabled.
5-(2-Chlorophenyl)-N-[3-(1H-tetrazol-5-yl)phenyl]thiophene-2-sulfonamide
ID: ALA3728043
PubChem CID: 56940874
Max Phase: Preclinical
Molecular Formula: C17H12ClN5O2S2
Molecular Weight: 417.90
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1cccc(-c2nnn[nH]2)c1)c1ccc(-c2ccccc2Cl)s1
Standard InChI: InChI=1S/C17H12ClN5O2S2/c18-14-7-2-1-6-13(14)15-8-9-16(26-15)27(24,25)21-12-5-3-4-11(10-12)17-19-22-23-20-17/h1-10,21H,(H,19,20,22,23)
Standard InChI Key: NYGSNBPWVRTPQO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2122 -3.8625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7464 -5.2884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7536 -5.2860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2149 -3.8587 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.6362 -6.4967 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.8294 -6.3690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.3436 -7.4661 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0288 -7.8691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.9129 -9.0819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3078 -10.4545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1939 -11.6648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6851 -11.5026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2903 -10.1301 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4042 -8.9198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7822 -9.9678 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7700 -11.0797 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1371 -10.4624 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9726 -8.9715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5037 -8.6673 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 2 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 12 1 0
12 8 1 0
11 13 1 0
13 14 2 0
13 15 2 0
13 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 417.90 | Molecular Weight (Monoisotopic): 417.0121 | AlogP: 4.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 100.63 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: ┄ | CX LogP: 3.94 | CX LogD: 1.57 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.51 | Np Likeness Score: -2.37 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |